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Sadaf Aslam, MD, MS2; Greg Matthew E. Teo, MD2; Teayoung Kim, MD1;
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Session: 276. Transplant ID: Parasitic Infections
Saturday, October 5, 2019: 12:15 PM
Background: Strongyloides stercoralis is a nematode endemic to the tropical and subtropical regions. In the United States, it is mostly found at southeastern states. Most infections are asymptomatic but disseminated and fatal
infections have been reported in immunocompromised patients. At our institution, universal screening through Strongyloides antibody detection in serum
among solid-organ transplant candidates began since 2010 and all seropositive
candidates are treated before transplantation. We previously determined our
incidence to be about 5%. The aim of this study was to determine demographic
characteristics and risk factors that can be used for more cost-effective targeted
screening.
Methods: We performed a retrospective cohort study of patients who underwent
transplant evaluation from 2014 to 2016. A total of 228 charts were reviewed for
Strongyloides serology status, eosinophilia, demographics and risk factors. Chi-square
and Fisher exact tests were used to do a comparative analysis between Strongyloides
seropositive and seronegative cohorts.
Results: We identified 113 seropositive (SP) patients and 115 seronegative (SN)
patients. There were more males in the seropositive group (79%) compared with seronegative group (62%) (P = 0.005). Caucasians predominated in both groups (SP 71%
vs. SN 57%; P = 0.286). No significant difference was found between both groups with
regards to occupation with soil or water contact (SP 38% vs. SN 30%; P = 0.281), birthplace outside USA or travel outside of United States (SP 31% vs. SN 36%; P = 0.732).
Eosinophilia occurred less in the seropositive group compared with the seronegative
group (SP 16% vs. SN 30%; P = 0.030).
Conclusion: The study did not find any statistically significant difference in
the demographic characteristics or risk factors that can be used for prediction of
Strongyloides seropositivity among solid-organ transplant candidates. Hence,
our institution will continue universal screening for Strongyloides stercoralis for
all our transplant candidates. Our findings further question donor screening for
Strongyloides that uses a similar questionnaire which may not be reliable to identify
those infected with this parasite. This would put recipients at risk for a donor-transmitted infection.
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Background: Toxoplasma gondii causes opportunistic infections in transplant
recipients after primary, donor-derived, or reactivated infection. Diagnosis in solid-organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients may
be delayed due to varied clinical presentations, which can mimic bacterial sepsis. These
delays could contribute to significant associated mortality, with a reported rate exceeding 50% in disseminated disease. Further exploration of expanded donor screening,
targeted recipient prophylaxis, and enhanced early detection may be warranted. We
therefore examined patient characteristics, clinical presentation, time to toxoplasmosis
diagnosis, and mortality in transplant recipients at two centers.
Methods: A retrospective chart review of SOT and HSCT recipients diagnosed with
toxoplasmosis from 2002–2018 at Emory Healthcare and Duke University Hospital
was performed, with cases identified via an electronic query of relevant ICD codes,
positive serum or CSF toxoplasmosis PCRs, and pathologic diagnoses. Patient characteristics, including age, sex, race, time since transplantation, method of toxoplasmosis
diagnosis, and symptoms, were abstracted. Primary outcomes included time from
transplant to diagnosis and estimated 30- and 90-day all-cause mortality.
Results: 16 patients were identified, with a median age of 56 years at diagnosis. 50%
were male, and the majority were white (63%) and SOT recipients (56%; see table).
Median time from transplant to diagnosis was 295 days, with PCR the most common
diagnostic modality (63%). In 31% of cases, toxoplasmosis was diagnosed after patient
death. The most common clinical presentations were encephalitis (69%), respiratory
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observational trial, the incidence of KS in different organ transplant recipients as well
as mortality were investigated.
Methods: Patient information was retrieved from the United Network for Organ
Sharing (UNOS) database to identify all liver, kidney, heart, or lung transplant recipients, and those who were subsequently diagnosed with KS. Patients were stratified by
transplant organ, clinical and demographic information was obtained to characterize
each population. Unadjusted differences in incidence, mortality, and patient characteristics were examined with chi-square or Fisher exact test for categorical variables; continuous variables were examined with the Kruskal–Wallis test which was Bonferroni
adjusted for multiple comparisons. Patients < 18 years of age, who had missing information concerning the development of a Kaposi’s sarcoma, or who underwent multiple
organ transplant were excluded. SAS, v. 9.4, was used for statistical analysis; P < 0.05
was considered significant.
Results: Patient demographics are described in Table 1. The development of KS
was significantly different among organ transplant types. Kidney transplant recipients had a higher incidence of KS in comparison to liver transplant recipients (P <
0.001). Mortality was the highest in lung transplant recipients who developed KS,
which was significantly higher than kidney (P < 0.001) or liver transplant recipients
(P = 0.005). Finally, it was determined that there was a significant difference in age
and race (white vs. non-white) among the various organ transplants (P < 0.001,
respectively)
Conclusion: Although incidence of KS is significantly higher post renal transplant,
mortality is highest in lung transplant recipients. Further investigation is needed to
understand differences in mortality among transplant recipients. This will help identify
at risk subjects and develop interventions to reduce mortality.

